Hjem
Gülen Arslan Lieds bilde

Gülen Arslan Lied

Professor
  • E-postGulen.Arslan@uib.no
  • Telefon+47 55 97 30 58
  • Besøksadresse
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2022). Intestinal barrier integrity in anorexia nervosa (a pilot study). International Journal of Eating Disorders. 703-708.
  • Vis forfatter(e) (2021). The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. Frontiers in Cellular and Infection Microbiology. 1-12.
  • Vis forfatter(e) (2021). Assessment of markers of gut integrity and inflammation in non-celiac gluten sensitivity after a gluten free-diet. International Journal of General Medicine. 9459-9470.
  • Vis forfatter(e) (2020). The effect of supplementation with low doses of a cod protein hydrolysate on satiety hormones and inflammatory biomarkers in adults with metabolic syndrome: A randomized, double-blind study. Nutrients. 1-13.
  • Vis forfatter(e) (2020). Supplementation with low doses of a cod protein hydrolysate on glucose regulation and lipid metabolism in adults with metabolic syndrome: A randomized, double-blind study. Nutrients. 1-15.
  • Vis forfatter(e) (2020). Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome. Medicine. 1-8.
  • Vis forfatter(e) (2020). Association between gastrointestinal complaints and psychopathology in patients with anorexia nervosa. International Journal of Eating Disorders. 532-536.
  • Vis forfatter(e) (2020). Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation . Gastroenterology Research and Practice. 1-9.
  • Vis forfatter(e) (2019). Supplementation with cod protein hydrolysate in older adults: A dose range cross-over study. Journal of Nutritional Science (JNS). 1-8.
  • Vis forfatter(e) (2019). Intraoperative anaphylaxis to gelatin-based hemostatic agents: a case report. Journal of Asthma and Allergy. 163-167.
  • Vis forfatter(e) (2019). Fish-derived proteins and their potential to improve human health. Nutrition reviews. 572-583.
  • Vis forfatter(e) (2019). Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome. Nutrients. 1-13.
  • Vis forfatter(e) (2019). Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels. Scandinavian Journal of Gastroenterology. 690-699.
  • Vis forfatter(e) (2019). Acute effect of a cod protein hydrolysate on postprandial acylated ghrelin concentration and sensations associated with appetite in healthy subjects: a double-blind crossover trial. Food & Nutrition Research. 1-9.
  • Vis forfatter(e) (2018). The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation. PLOS ONE. 1-17.
  • Vis forfatter(e) (2018). The effect of a controlled gluten challenge in a group of patients with suspected non-coeliac gluten sensitivity: A randomized, double-blind placebo-controlled challenge. Neurogastroenterology and Motility. 1-10.
  • Vis forfatter(e) (2018). Exploring gut microbiota composition as an indicator of clinical response to dietary FODMAP restriction in patients with irritable bowel syndrome. Digestive Diseases and Sciences. 429-436.
  • Vis forfatter(e) (2018). Effect of a cod protein hydrolysate on postprandial glucose metabolism in healthy subjects: A double-blind cross-over trial. Journal of Nutritional Science (JNS). 9 sider.
  • Vis forfatter(e) (2018). Does the low FODMAP diet improve symptoms of radiation-induced enteropathy? A pilot study. Scandinavian Journal of Gastroenterology. 541-548.
  • Vis forfatter(e) (2018). Altered levels of cytokines in patients with irritable bowel syndrome are not correlated with fatigue. International Journal of General Medicine. 285-291.
  • Vis forfatter(e) (2017). Red meat allergy induced by tick bites: A Norwegian case report. European Annals of Allergy and Clinical Immunology. 186-188.
  • Vis forfatter(e) (2017). Gastric accommodation in healthy subjects studied by ultrasound, manometry, and impedancemetry. Neurogastroenterology and Motility. 1-9.
  • Vis forfatter(e) (2017). Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterology and Motility. 1-9.
  • Vis forfatter(e) (2016). Functional gastrointestinal symptoms are associated with higher serum total IgE levels, but less atopic sensitization. Digestive Diseases and Sciences. 189-197.
  • Vis forfatter(e) (2016). Extra-intestinal symptoms in patients with irritable bowel syndrome: related to high total IgE levels and atopic sensitization? Scandinavian Journal of Gastroenterology. 908-913.
  • Vis forfatter(e) (2014). Indication of immune activation in patients with perceived food hypersensitivity. Digestive Diseases and Sciences. 259-266.
  • Vis forfatter(e) (2013). Tetradecylthioacetic acid attenuates inflammation and has antioxidative potential during experimental colitis in rats. Digestive Diseases and Sciences. 97-106.
  • Vis forfatter(e) (2013). Forskningsveiledning - en av de essensielle faktorene på «veien til doktorgrad». UNIPED. 45-54.
  • Vis forfatter(e) (2012). Increased wall thickness using ultrasonography is associated with inflammation in an animal model of experimental colitis. Clinical and Experimental Gastroenterology. 195-201.
  • Vis forfatter(e) (2011). Subjective food hypersensitivity: assessment of enterochromaffin cell markers in blood and gut lavage fluid. International Journal of General Medicine. 555-560.
  • Vis forfatter(e) (2011). Dendritic cell populations in patients with self-reported food hypersensitivity. International Journal of General Medicine. 389-396.
  • Vis forfatter(e) (2010). Job stress and coping strategies in patients with subjective food hypersensitivity. Scandinavian Journal of Psychology. 179-184.
  • Vis forfatter(e) (2010). Intestinal B cell-activating factor: an indicator of non-IgE mediated hypersensitivity reactions to food? Alimentary Pharmacology and Therapeutics. 66-73.
  • Vis forfatter(e) (2010). Indications of 'atopic bowel' in patients with self-reported food hypersensitivity. Alimentary Pharmacology and Therapeutics. 1112-1122.
  • Vis forfatter(e) (2010). Duodenal administered seal oil for patients with subjective food hypersensitivity: an explorative open pilot study. International Journal of General Medicine. 383-392.
  • Vis forfatter(e) (2010). Do psychological factors predict symptom severity in patients with subjective food hypersensitivity? Scandinavian Journal of Gastroenterology. 835-843.
  • Vis forfatter(e) (2010). Anxiety and depression in patients with self-reported food hypersensitivity. General Hospital Psychiatry. 42-48.
  • Vis forfatter(e) (2009). Sonography of the small intestine. World Journal of Gastroenterology (WJG). 1319-1330.
  • Vis forfatter(e) (2009). Predictive value and clinical significance of myenteric plexitis in Crohn`s disease. Inflammatory Bowel Diseases. 1499-1507.
  • Vis forfatter(e) (2009). Clinical and surgical recurrence of Crohn`s diases after ileocolonic resection in a specialist unit. European Journal of Gastroenterology and Hepathology. 551-557.
  • Vis forfatter(e) (2008). Lifestyle of patients with self-reported food hypersensitivity differ little from controls. Gastroenterology Nursing. 401-410.
  • Vis forfatter(e) (2008). Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: A pilot study comparing seal oil and cod liver oil. Clinical Nutrition. 614-622.
  • Vis forfatter(e) (2008). Effects of seal oil on meal-induced symptoms and gastric accommodation in patients with subjective food hypersensitivity. A pilot study. Clinical Medicine : Gastroenterology. 33-41.
  • Vis forfatter(e) (2007). No Protection against DSS-induced Colitis by Short-term Pretreatment with Seal or Fish Oils in Rats. Integrative Medicine Insights. 25-34.
  • Vis forfatter(e) (2006). Short-term duodenal seal oil administration normalised n-6 to n-3 fatty acid ratio in rectal mucosa and ameliorated bodily pain in patients with inflammatory bowel disease. Lipids in Health and Disease.
  • Vis forfatter(e) (2006). Food Hypersensitivity Reactions Visualised by Ultrasonography and Magnetic Resonance Imaging in a Patient Lacking Systemic Food-Specific IgE. Digestion. 111-115.
  • Vis forfatter(e) (2005). Subjective health complaints and modern health worries in patients with subjective food hypersensitivity. Digestive Diseases and Sciences. 1245-1251.
  • Vis forfatter(e) (2005). Response to intestinal provocation monitored by transabdominal ultrasound in patients with food hypersensitivity. Scandinavian Journal of Gastroenterology. 386-394.
  • Vis forfatter(e) (2005). Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis. Inflammatory Bowel Diseases. 744-748.
  • Vis forfatter(e) (2005). Gastrointestinal matoverfølsomhet – et økende problem i befolkningen. Norsk tidsskrift for ernæring (NTFE). 4-6.
  • Vis forfatter(e) (2005). Gastrointestinal matoverfølsomhet hos voksne - nye studier om mulige årsaker. Fagbladet Allergi i praksis. 12-17.
  • Vis forfatter(e) (2005). Food hypersensitivity-immunologic (peripheral) or cognitive (central) sensitisation? Psychoneuroendocrinology. 983-989.
  • Vis forfatter(e) (2005). Berstad A. Matoverfølsomhet hos voksne – nye studier om mulige årsaker. Fagbladet Allergi i praksis. 12-17.
  • Vis forfatter(e) (2005). An acute stressor enhances sensitivity to a chemical irritant and increases 51-CrEDTA permeability of the colon in adult rats. Integrative Physiological & Behavioral Science. 35-44.
  • Vis forfatter(e) (2004). Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scandinavian Journal of Gastroenterology.
  • Vis forfatter(e) (2004). Quality of life in patients with subjective food hypersensitivity: Applicability of the 10-item short form of the Nepean Dyspepsia Index. Digestive Diseases and Sciences. 680-687.
  • Vis forfatter(e) (2004). Patients with subjective food hypersensitivity: The value of analysing intestinal permeability and inflammation markers in gut lavage fluid. Digestion. 26-35.
  • Vis forfatter(e) (2003). Intestinal permeability and faecal granulocyte marker protein in dextran sulphate sodium - induced colitis in rats. Scandinavian Journal of Laboratory Animal Science. 169-175.
  • Vis forfatter(e) (2002). Food allergy and intolerance: response to intestinal provocation monitored by endosonography. European Journal of Ultrasound. 29-36.
  • Vis forfatter(e) (2002). Effects of duodenal seal oil administration in patients with inflammatory bowel disease. Lipids. 935-940.
  • Vis forfatter(e) (2001). Serum eosinophilic cationic protein: A marker of eosinophilic infiltration in inflammatory bowel disease? The Turkish Journal of Gastroenterology. 136-140.
  • Vis forfatter(e) (2001). 51CrEDTA colonic permeability and therapy response in ulcerative colitis. Nuclear medicine communications. 997-1001.
  • Vis forfatter(e) (2000). Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid. Scandinavian Journal of Gastroenterology.
  • Vis forfatter(e) (2000). Assessment of intestinal permeability using 51CrEDTA in inflammatory bowel disease. The Turkish Journal of Gastroenterology. 320-325.
Faglig foredrag
  • Vis forfatter(e) (2018). IgE- and non-IgE-mediated enteropathies in adults.
  • Vis forfatter(e) (2018). Food hypersensitivity in adults.
  • Vis forfatter(e) (2017). Kasuistikk. Matvareallergi og matvareintoleranse.
  • Vis forfatter(e) (2017). Cøliaki og non-cøliakisk gluten intoleranse.
  • Vis forfatter(e) (2017). Allergic, IgE /non-IgE enteropathies in adults.
  • Vis forfatter(e) (2016). Selvrapportert matoverfølsomhet.
  • Vis forfatter(e) (2016). Matallergi/intoleranse hos voksne.
  • Vis forfatter(e) (2016). Kinetics of microbial community composition in patients with diarrhea-predominant irritable bowel syndrome following faecal microbiota transplantation.
  • Vis forfatter(e) (2015). The relation between supervisor and candidate.
  • Vis forfatter(e) (2015). Kasuistikk. Matvareallergi og matvareintoleranse.
  • Vis forfatter(e) (2015). Food hypersensitivity in adults.
  • Vis forfatter(e) (2015). Allergic, IgE /non-IgE enteropathies.
  • Vis forfatter(e) (2014). The relation between candidate and supervisor.
  • Vis forfatter(e) (2014). Subjektiv matoverfølsomhet.
  • Vis forfatter(e) (2014). Allergiske, IgE-/non-IgE-enteropatier: Voksne.
  • Vis forfatter(e) (2013). Matoverfølsomhet hos voksne.
Populærvitenskapelig foredrag
  • Vis forfatter(e) (2019). Gluten intolerance, food allergy and irritable bowel syndrome.
  • Vis forfatter(e) (2015). Food intolerance and gastrointestinal complaints.
  • Vis forfatter(e) (2011). A comparison between DSS- and TNBS induced colitis in rats on ultrasonographic intestinal changes: a pilot study.
Vitenskapelig foredrag
  • Vis forfatter(e) (2021). What is New in the Treatment of Celiac Disease?
  • Vis forfatter(e) (2021). Therapeutiske veier ved dysbiose.
  • Vis forfatter(e) (2021). Therapeutic Approaches against Dysbiosis.
  • Vis forfatter(e) (2021). Kort- og langtidseffekten av lav FODMAP-dietten på symptomer og kortkjedede fettsyrer hos pasienter med irritabel tarmsyndrom.
  • Vis forfatter(e) (2021). Alpha-Gal (kjøttallergi) og gelatin allergi.
  • Vis forfatter(e) (2020). Therapeutic Approaches for Dysbiosis.
  • Vis forfatter(e) (2020). Short and extended effects of a low FODMAP diet on symptoms and short-chained fatty acids in patients with irritable bowel syndrome.
  • Vis forfatter(e) (2020). Non-celiac gluten sensitivity and the spectrum of the gluten related disorders.
  • Vis forfatter(e) (2020). Kvalitetsevaluering av tverrfaglig IBS-poliklinikk .
  • Vis forfatter(e) (2020). Kort- og langtidseffekten av lavFODMAP-diett på symptomer og mikrobiota hos pasienter med IBS .
  • Vis forfatter(e) (2019). Non-coeliac gluten sensitivity and the spectrum of gluten-related disorders.
  • Vis forfatter(e) (2019). Non-Coeliac Gluten Sensitivity And The Spectrum Of Gluten-Related Disorders: An Updated Overview.
  • Vis forfatter(e) (2019). Matallergi og intoleranser.
  • Vis forfatter(e) (2019). Mage-tarmskolen – tverrfaglig internetbehandling ved Irritabel tarmsyndrom .
  • Vis forfatter(e) (2019). Irritabel bowel syndrome - interdisciplinary treatment options .
  • Vis forfatter(e) (2019). Gut microbiota and therapeutic approaches for dysbiosis: Recent developments and future perspectives.
  • Vis forfatter(e) (2019). Gut microbiota and therapeutic approaches for dysbiosis.
  • Vis forfatter(e) (2019). Effect of faecal microbiota transplantation on gut microenvironment and symptoms in patients with irritable bowel syndrome.
  • Vis forfatter(e) (2018). Microbiota 2018.
  • Vis forfatter(e) (2018). Is non-celiac gluten sensitivity out?
  • Vis forfatter(e) (2018). Fecal Microbiota transplantation.
  • Vis forfatter(e) (2017). Microbial DNA markers associated with response to a low FODMAP diet in patients with irritable bowel syndrome.
  • Vis forfatter(e) (2017). An overview of potential pathophysiological mechanisms in food hypersensitivity.
  • Vis forfatter(e) (2017). An Overview of Gluten-Related Disorders.
  • Vis forfatter(e) (2016). Low FODMAP diet alters symptoms, microbiota, short-chain fatty acids and cytokine profiles in patients with IBS: A randomized controlled trial.
  • Vis forfatter(e) (2016). Low FODMAP diet alters symptoms, microbiota, short-chain fatty acids and cytokine profiles in patients with IBS: A randomized controlled trial.
  • Vis forfatter(e) (2016). Digestive Health - the role of protein nutrition on gut microbiota and the pathogenesis of gastrointestinal disorders?
  • Vis forfatter(e) (2015). Intestinal permeabilitet hos friske personer etter inntak av NSAIDs: en pilotstudie.
  • Vis forfatter(e) (2013). Veien til doktorgraden: Forskningsveiledning.
  • Vis forfatter(e) (2012). Matoverfølsomhet.
  • Vis forfatter(e) (2011). Ultrasonographic evaluation of DSS-induced colitis in rats after dietary intake of a modified thia fatty acid.
  • Vis forfatter(e) (2010). Potential Role of B Cell-Activating Factor (BAFF) in Non-IgE-mediated Hypersensitivity Reactions to Food.
  • Vis forfatter(e) (2009). Potential Role of B Cell-Activating Factor (BAFF) in Non-IgE-mediated Hypersensitivity Reactions to Food.
  • Vis forfatter(e) (2009). Indications of `atopic bowel` in patients with irritable bowel syndrome (IBS).
  • Vis forfatter(e) (2006). Intestinal Food Hypersensitivity.
  • Vis forfatter(e) (2005). Effekt av selolje vs soyaolje på leddsmerter ved inflammatorisk tarmsykdom.
  • Vis forfatter(e) (1998). Correlation between intestinal permeability and luminal calprotectin concentration.
Anmeldelse
  • Vis forfatter(e) (2021). Minneord: Arnold Berstad (1940-2020). Tidsskrift for Den norske legeforening. 293-293.
Populærvitenskapelig artikkel
  • Vis forfatter(e) (2021). Brain-Gut-Microbiota Interaction in Irritable Bowel Syndrome: A Multidimensional Approach. NBS-nytt. 19-21.
  • Vis forfatter(e) (2020). Kronprins Haakons forskningspris til Gülen Arslan Lied. NGF-nytt. 32.
  • Vis forfatter(e) (2018). Lav FODMAP-diett for pasienter med stråleskadet tarm. NGF-nytt. 30-32.
  • Vis forfatter(e) (2017). Ikke-cøliakisk gluten sensitivitet. NGF-nytt. 24-25.
Kronikk
  • Vis forfatter(e) (2021). Cøliaki er en sykdom, det er ikke en trend. Bergensavisen. 24-24.
Doktorgradsavhandling
  • Vis forfatter(e) (2021). Supplementation with cod protein hydrolysate: Intervention studies in healthy adults and adults with metabolic syndrome.
  • Vis forfatter(e) (2020). Health effects of supplementation with cod protein hydrolysate: Impact on glucose metabolism and appetite in healthy subjects and gut health in irritable bowel syndrome.
  • Vis forfatter(e) (2013). Subjective food hypersensitivity: Studies on enterochromaffin cell secretion products and effects of seal oil therapy.
  • Vis forfatter(e) (2010). Subjective food hypersensitivity: Lifestyle and psychological factors.
  • Vis forfatter(e) (2010). Self-reported food hypersensitivity with gastrointestinal symptoms. Allergological and psychological factors.
Intervju
  • Vis forfatter(e) (2022). People who remained sick long after their COVID-19 infection often had alterations in their intestinal bacteria.
  • Vis forfatter(e) (2022). De som var lenge syke etter covid-19, hadde ofte forstyrrelser i tarm­bakteriene.
  • Vis forfatter(e) (2021). Matallergier har økt dramatisk. Nå kommer forskere med en ny teori om hvorfor.
  • Vis forfatter(e) (2021). Et kaos av dietter - Hva er den beste dietten for oss med fordøyelsesssykdommer?
  • Vis forfatter(e) (2020). Kronprins Haakons forskningspris til Haukelandforsker.
  • Vis forfatter(e) (2020). Forskningsprisvinner er ledende på matallergi og intoleranser.
  • Vis forfatter(e) (2020). Eksperter kaller matintoleranse­tester for svindel. Ina (26) fikk påvist intoleranse hun ikke hadde.
  • Vis forfatter(e) (2020). Astma- og allergipris til Gülen Arslan Lied.
  • Vis forfatter(e) (2019). Probiotika kan hjelpe på magetrøbbel.
  • Vis forfatter(e) (2019). Probiotika kan hjelpe på magetrøbbel.
  • Vis forfatter(e) (2019). IBS-pasienter ble bedre i magen etter bæsj-transplantasjon.
  • Vis forfatter(e) (2018). Nina Kristiansen utelater et viktig budskap om vår forskning på glutensensitivitet.
  • Vis forfatter(e) (2018). Mente selv at de ikke tålte gluten, men ble ikke verre av å spise gluten.
  • Vis forfatter(e) (2018). Glutenstøtten kan bli kraftig redusert.
  • Vis forfatter(e) (2016). Studerte placebo-effekten ved kosthold.
  • Vis forfatter(e) (2015). Slik får du fart på magen.
  • Vis forfatter(e) (2014). Spesialistfront mot allergi.
  • Vis forfatter(e) (2014). Karrierevegar sentralt på Orpheus-konferansen 2014.
  • Vis forfatter(e) (2012). Matallergi. Diagnostisk manuel for voksne (DM voksen).
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
  • Vis forfatter(e) (2013). alfa-gal-allergi (kjøttallergi). 3 sider.
  • Vis forfatter(e) (2013). Matintoleranse og allergi i gastrointestinaltraktus. 3 sider.
Sammendrag/abstract
  • Vis forfatter(e) (2018). Interdisciplinary self- help intervention for IBS - eHealth and patient education. Neurogastroenterology and Motility. 182-183.
  • Vis forfatter(e) (2018). Effects of faecal microbiota transplantation on gut microenvironment and symptoms in patients with irritable bowel syndrome. Neurogastroenterology and Motility. 178-179.
  • Vis forfatter(e) (2017). The effect of a controlled gluten challenge in patients with suspected non-coeliac gluten sensitivity: A randomized, double-blind placebo-controlled challenge. Clinical Nutrition. 32-33.
  • Vis forfatter(e) (2017). Microbial DNA markers associated with response to a low FODMAP diet in patients with irritable bowel syndrome. Gastroenterology. S-44-S-45.
  • Vis forfatter(e) (2017). Low FODMAP diet improves symptoms and quality of life in patients with radiation-induced small bowel disease: A pilot study. Neurogastroenterology and Motility. 70-71.
  • Vis forfatter(e) (2017). Low FODMAP diet improves symptoms and quality of life in patients with radiation-induced small bowel disease: A pilot study. Clinical Nutrition. 207-208.
  • Vis forfatter(e) (2017). Gluten causes symptom relapse in a small group of patients with suspected non-celiac gluten sensitivity: A randomized, double-blind placebo controlled challenge. Neurogastroenterology and Motility. 68-69.
  • Vis forfatter(e) (2017). Effect of faecal microbiota transplantation on the symptoms and gut microbiota in patients with irritable bowel syndrome (IBS). Neurogastroenterology and Motility. 73-74.
  • Vis forfatter(e) (2017). Effect of faecal microbiota transplantation on gut bacterial fermentation products in patients with irritable bowel syndrome. United European Gastroenterology journal. A563-A564.
  • Vis forfatter(e) (2017). Effect of faecal microbiota transplantation on Neurogenin 3, Musahsi 1 and enteroendocrine cells in the duodenum of patients with irritable bowel syndrome. United European Gastroenterology journal. 785-786.
  • Vis forfatter(e) (2016). The Gastric Accomodation Reflex Studied by Ultrasound, Manometry and Impedancemetry in a Pilot Study. United European Gastroenterology journal. 675-675.
  • Vis forfatter(e) (2016). Low FODMAP diet alters symptoms, microbiota, short-chain fatty acids and cytokine profiles in patients with IBS: A randomized controlled trial. United European Gastroenterology journal. A101-A101.
  • Vis forfatter(e) (2016). Kinetics of microbial community composition in patients with diarrhea-predominant irritable bowel syndrome following faecal microbiota transplantation. United European Gastroenterology journal. LB11-LB11.
  • Vis forfatter(e) (2016). High levels of serum total IgE-antibodies are not related to intestinal and extra-intestinal symptom severity in irritable bowel syndrome. Neurogastroenterology and Motility. 63-63.
  • Vis forfatter(e) (2016). Effect of fecal microbiota transplantation on the symptoms and duodenal enteroendocrine cells in patients with irritable bowel syndrome. United European Gastroenterology journal. 677-677.
  • Vis forfatter(e) (2015). Atopic sensitization and functional gastrointestinal symptoms: Is there any relation? Gastroenterology. 778.
  • Vis forfatter(e) (2014). Are total immunoglobulin E and atopic sensitization associated with food-related gastrointestinal complaints? Neurogastroenterology and Motility. 42.
  • Vis forfatter(e) (2010). Dendritic cell populations in patients with self-reported food hypersensitivity. Gut. A394.
  • Vis forfatter(e) (2009). Potential role of B-cell activating factor in non-IgE-mediated hypersensitivity reactions to food. Gut. A116-A116.
  • Vis forfatter(e) (2009). Indications of `atopic bowel` in patients with irritable bowel syndrome (IBS). Neurogastroenterology and Motility. 7-7.
  • Vis forfatter(e) (2009). Indications of "atopic bowel" in patients with irritable bowel syndrome. Gut. A20-A20.
  • Vis forfatter(e) (2008). Cross-sectional study on the correlation between pre-operative azathioprine and myenteric plexitis in the proximal resection margins and affected Crohn's disease segment. Gastroenterology. 687-687.
  • Vis forfatter(e) (2004). Calprotectin in faeces and gut lavage fluid; relationship to intestinal permeability and disease activity in IBD. Scandinavian Journal of Gastroenterology. 8-8.
  • Vis forfatter(e) (2003). Subjective health complaints and quality of life in patients with self-reported adverse reactions to food. Scandinavian Journal of Gastroenterology, Supplement. 15-15.
  • Vis forfatter(e) (2003). Seal oil compared to soy oil in patients with inflammatory bowel disease. Gastroenterology. 67-67.
Poster
  • Vis forfatter(e) (2009). Indications of "atopic bowel" in patients with irritable bowel syndrome.
Errata
  • Vis forfatter(e) (2019). Effect of a cod protein hydrolysate on postprandial glucose metabolism in healthy subjects: A double-blind cross-over trial - CORRIGENDUM. Journal of Nutritional Science (JNS). 1-2.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2022). Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome. World Journal of Gastroenterology (WJG). 412-431.
  • Vis forfatter(e) (2020). Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives. Turkish Journal of Medical Sciences. 1632-1641.
  • Vis forfatter(e) (2020). Effects of plant-based diets on weight status: A systematic review. Diabetes, Metabolic Syndrome and Obesity. 3433-3448.
  • Vis forfatter(e) (2020). Effects of plant-based diets on outcomes related to glucose metabolism: A systematic review. Diabetes, Metabolic Syndrome and Obesity. 2811-2822.
  • Vis forfatter(e) (2020). Comparison of gut microbiota profile in celiac disease, non-celiac gluten sensitivity and irritable bowel syndrome: A systematic review. The Turkish Journal of Gastroenterology. 735-745.
  • Vis forfatter(e) (2019). Probiotics in irritable bowel syndrome: An up-to-date systematic review. Nutrients. 1-15.
  • Vis forfatter(e) (2018). Non-coeliac gluten sensitivity and the spectrum of gluten-related disorders: an updated overview. Nutrition research reviews. 1-10.
  • Vis forfatter(e) (2017). An overview of potential pathophysiological mechanisms in food hypersensitivity. J Gastrointest Dig Syst. 16-17.
  • Vis forfatter(e) (2014). Spekter av gluten-relaterte lidelser. Utposten. 30-31.
  • Vis forfatter(e) (2014). Immunsystemets rolle ved selvrapportert matoverfølsomhet. BestPractice Gastroenterologi. 12-15.
  • Vis forfatter(e) (2011). Perceived food hypersensitivity: A review of 10 years of interdisciplinary research at a reference center. Scandinavian Journal of Gastroenterology. 1169-1178.
  • Vis forfatter(e) (2011). Pasienten tåler ikke mat - hva skal vi tro? Utposten. 36-40.
  • Vis forfatter(e) (2011). Matoverfølsomhet- Et paradigmeskifte? Fagbladet Allergi i praksis. 30-33.
  • Vis forfatter(e) (2011). Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review. Scandinavian Journal of Immunology. 1-7.
  • Vis forfatter(e) (2009). Matoverfølsomhet og funksjonelle mage-tarmsykdommer: Hvilke punkter er viktige ved første konsultasjon? Utposten. 18-23.
  • Vis forfatter(e) (2007). Gastrointestinal food hypersensitivity: Symptoms, diagnosis and provocation tests. The Turkish Journal of Gastroenterology. 5-13.
  • Vis forfatter(e) (1999). Intestinal allergi. Therapia medica. 10-12.
Fagartikkel
  • Vis forfatter(e) (2017). Nutrition, health and chronic diseases. Indremedisineren. 16-18.
  • Vis forfatter(e) (2015). Matoverfølsomhet - den nye folkesykdommen? Bioingeniøren. 16-17.
  • Vis forfatter(e) (2015). An overview of spectrum of gluten-related disorders. Güncel Gastroenteroloji (Turky). 87-90.
Intervju tidsskrift
  • Vis forfatter(e) (2019). Matvareoverfølsomhet og -allergi. LMF.

Se fullstendig oversikt over publikasjoner i CRIStin.